Visualizing Antigen-Specific and Infected Cells in Situ Predicts Outcomes in Early Viral Infection
In the early stages of viral infection, outcomes depend on a race between expansion of infection and the immune response generated to contain it. We combined in situ tetramer staining with in situ hybridization to visualize, map, and quantify relationships between immune effector cells and their targets in tissues. In simian immunodeficiency virus infections in macaques and lymphocytic choriomeningitis virus infections in mice, the magnitude and timing of the establishment of an excess of effector cells versus targets were found to correlate with the extent of control and the infection outcome (i.e., control and clearance versus partial or poor control and persistent infection). This method highlights the importance of the location, timing, and magnitude of the immune response needed for a vaccine to be effective against agents of persistent infection, such as HIV-1.
T he outcome of viral infections in the acute stage of infection can be thought of as a numbers game and race, with the magnitude and speed of mounting host defenses competing against virus propagation and spread (1) . Generally, in self-limited and fully controlled infections, the host wins by quickly generating large numbers of virus-specific cytotoxic T lymphocytes (CTLs) that terminate infection by clearing infected cells. However, a virus can win, and can establish a persistent infection, when the cellular immune response is delayed and is of insufficient magnitude to clear infection. The outcome then depends on the extent to which the CTL response can control infection and prevent progression to disease.
We studied correlates of these different outcomes of infection in simian immunodeficiency virus (SIV) and lymphocytic choriomeningitis virus (LCMV) infections. SIV (and HIV-1) cause persistent infections in which the CTL response in the early stages of infection (2, 3) is too little and too late (4-7) to prevent systemic infection and massive depletion of CD4 + T cells in the gut (8) (9) (10) , but is usually sufficient to partially control virus production (2, 3) . LCMV strains cause infections in which the outcome may be clearance or persistence, depending on the strain: Infection with LCMV-Armstrong is cleared from adult C57B1/6 mice by 8 days post-inoculation (dpi), whereas animals infected with LCMV-clone 13 remain persistently viremic for months (11, 12) .
To identify correlates of clearance and the extent of control in persistent infections, we investigated the relationship between increasing numbers of infected cells and virus-specific CTLs in the early stages of SIV and LCMV infections. We hypothesized that the outcomes of infection would be determined by the timing, ratio, and spatial colocalization of virus-specific CTLs to infected cells. We tested this hypothesis with a method (13) called ISTH, as it combines in situ tetramer (IST) staining (14) and in situ hybridization (ISH) to locate and enumerate virus-specific tetramer + T cells and viral RNA + cells in tissues, using these as measures, respectively, of virus-specific CTLs and infected cells.
After intravaginal inoculation of SIV into adult female rhesus macaques, virus replicates in the first week in cervical vaginal tissues and then spreads throughout the lymphatic tissues to reach a peak in numbers of infected cells at 10 to 14 dpi (8, 15) . The peak in viral replication precedes the cellular immune response to immunodominant epitopes in SIV Gag and Tat that together constitute 70% of the cellular immune response in acute infection (16) . This response is not detected until 14 dpi (7), which is too late to prevent a robust systemic infection. However, numbers of SIV RNA + cells do decline between 14 and 28 dpi, at a time coinciding with the detection of increasing numbers of Gag-and Tat-tetramer + cells by fluorescence-activated cell sorting (FACS) analysis and IST staining (7) .
This decline in SIV RNA + cells was greater in cervical vaginal tissues than in lymphatic tissues (15) , consistent with the hypothesis that the extent of control in each tissue compartment was related to the spatial proximity and numbers of tetramer + cells relative to the numbers of SIV RNA + cells. We used ISTH to test this hypothesis by visualizing, in the same section, effector (E) tetramer + cells and target (T) SIV RNA + cells, and then determining E:T cell ratios and the spatial proximity of tetramer + cells to their targets in cervical vaginal and lymphatic tissues (13) .
We indeed found that the decline in numbers of infected cells in the cervix between the peak and 21 dpi (fig. S1, A and B) was correlated with detection by ISTH (Fig. 1A) of Gag-tetramer + cells in close spatial proximity to one another throughout the lymph node. We thus conclude that effectors and targets are in close spatial proximity in these two tissue compartments.
By using ISTH to determine E:T ratios, we could further show that these ratios correlated with the extent of virus control in each tissue compartment. Defining extent of control as the reduction from peak numbers of copies of SIV RNA per microgram of tissue RNA to copy numbers at 20, 21, and 28 dpi, when the animals had mounted a tetramer response and viral load data were available from previously reported studies (15), we found a statistically significant relationship between the E:T ratio and relative reduction (P = 0.001). Reductions in viral loads by a factor of 80 to 160 were correlated with E:T ratios of ≥100. These ratios, with one exception, were achieved only in the female reproductive tract tissues where initial exposure and virus replication had elicited the most robust response.
We next investigated the relationship between the timing and magnitude of the effector response to infection outcome in LCMV-Armstrong and LCMV-clone 13 infections. LCMV-Armstrong infections are rapidly cleared by the second week of infection, whereas LCMV-clone 13 infections continue at high levels for months, with debilitating effects on virus-specific CTL proliferation and function mediated by programmed cell death-1 (PD-1) and its ligands (11, 12, 15, 17) . Because the two amino acid differences between LCMV-Armstrong and LCMV-clone 13 do not alter dominant or subdominant epitopes (18, 19) , it is not yet clear Fig. 1. ISTH analysis. (A 
We determined by ISTH that strain LCMVArmstrong is cleared because the number of immune effectors rapidly exceeds the number of infected cells. LCMV-clone 13, on the other hand, immediately infects larger numbers of macrophages (18) and fibroreticular cells (FRCs) (20) than does LCMV-Armstrong, thereby exceeding the capacity of the initial immune response to reduce the basic reproductive rate below 1 and thereby contain infection.
The divergent outcome and larger number of cells infected by LCMV-clone 13 in the spleen are illustrated in Fig. 3 , which tracks LCMV RNA + cells and LCMV-antigen + FRCs (13) in the spleen from 1 to 8 dpi for the respective strains. As previously described, both strains of LCMV infect splenic marginal zone macrophages and FRCs in the white pulp, but LCMV-clone 13 infects larger numbers of both cell types (18, 20) . This difference, particularly the infection of FRCs, is already evident at 1 dpi, as judged by the diffuse ISH signal emanating from LCMV RNA + cells in the white pulp. LCMV-clone 13 infection of both cell types is sustained at high levels at 3, 5, and 8 dpi, whereas the numbers of LCMV-Armstronginfected cells are barely detectable by 8 dpi.
The different infection outcomes produced by these two strains of LCMV cannot be explained by differences in the immune response seen in FACS analysis, but can be explained by ISTH, which provides the critical relevant measure of relative rates of increase in effectors and targets.
By FACS analysis, the rapidly expanding populations of virus-specific tetramer + T cells were comparable for both strains from 3 to 8 dpi (Fig.  4A) . However, E:T ratios determined by ISH reflect the increase of infected cells (relative to LCMV-GP and NP-tetramer + cells) in LCMVclone 13 infection versus LCMV-Armstrong infection (Fig. 4B) . Because of the faster increase of infected cells relative to LCMV-tetramer + cells, the E:T ratio for LCMV-clone 13 never approached 1. By contrast, the E:T ratio for LCMV-Armstrong was already~4 at 3 dpi, higher than the ratio for LCMV-clone 13 at 3 dpi by a factor of 20.
Together, the ISTH analyses of SIVand LCMV infection tell us that location, timing, and numbers of effectors and targets all count in determining outcome. We have speculated elsewhere (5) that if the "too little, too late" response to SIV infection (7) had occurred earlier, when there were only small founder populations of infected cells confined to the portal of entry, vaginal transmission and systemic infection might be prevented with relatively few effector cells. Thus, in SIV (and, by extension, HIV-1) infections, a vaccine that elicited an immune response at the portal of entry "enough and soon enough" could prevent vaginal transmission. To generate efficient vaccines and cures for Mycobacterium tuberculosis, we need a far better understanding of its modes of infection, persistence, and spreading. Host cell entry and the establishment of a replication niche are well understood, but little is known about how tubercular mycobacteria exit host cells and disseminate the infection. Using the social amoeba Dictyostelium as a genetically tractable host for pathogenic mycobacteria, we discovered that M. tuberculosis and M. marinum, but not M. avium, are ejected from the cell through an actin-based structure, the ejectosome. This conserved nonlytic spreading mechanism requires a cytoskeleton regulator from the host and an intact mycobacterial ESX-1 secretion system. This insight offers new directions for research into the spreading of tubercular mycobacteria infections in mammalian cells.
Infection by Tubercular Mycobacteria Is Spread by Nonlytic Ejection from Their Amoeba Hosts
I ntracellular bacterial pathogens have evolved strategies to exploit host cell resources and replicate inside a variety of cell types, staying out of reach of the host's immune system. The concept is emerging that pathogenic bacteria evolved from environmental species by adapting to an intracellular lifestyle within free-living bacteria-eating protozoans. Consequently, cellular defense mechanisms that are active in animal immune phagocytes may have originated in amoebas (1, 2). For example, during differentiation of the social amoeba Dictyostelium to form a multicellular structure, sentinel cells are deployed to combat pathogens (1) .
Generally, infection follows the entry of a bacterium into a host cell, giving rise to a pathogencontaining vacuole usually called a phagosome.
From this common starting point, pathogens subvert or resist the mechanisms that usually transform the phagosome into a bactericidal environment. Understanding of the passive or triggered uptake mechanisms and of the subsequent hijacking of host cell processes is increasing steadily, but little is known about how the pathogens exit their primary host cells and spread the infection.
Mycobacterium tuberculosis causes tuberculosis and other granulomatous lesions and is a major threat to human health. M. marinum is a close relative (3) responsible for fish and amphibian tuberculosis, in which it causes almost indistinguishable pathologies and lesions [reviewed in (4) ]. Several elegant cross-species complementation studies between these two pathogens highlight their common mechanisms of pathogenicity [reviewed in (4) ].
After passive uptake by immune phagocytes, M. tuberculosis and M. marinum arrest or bypass phago-lysosome maturation and replicate inside a compartment of endosomal nature (5-7).
